Agnès Hoffenbach

721 citations

18 papers · 531 indexed · h-index 12

Impact in

Microbiology top 1%
- Bacterial Infections and Vaccines
Epidemiology top 10%
- Pneumonia and Respiratory Infections
- Influenza Virus Research Studies
- Respiratory viral infections research

Papers in

Microbiology 8
- Bacterial Infections and Vaccines 8
Epidemiology 16
- Influenza Virus Research Studies 8
- Pneumonia and Respiratory Infections 5
- Hepatitis B Virus Studies 4
- Respiratory viral infections research 3

Co-authors: Mark A. Fletcher Gary N. Sanden Isabelle Iteman Emmanuel Vidor Marie‐Pierre Préziosi Steven G.F. Wassilak Coumba Touré Kane M. Cadoz
Journals: Vaccine (5 papers)Current Medical Research and Opinion (2 papers)Human Vaccines (2 papers)Cellular Immunology (2 papers)Human Vaccines & Immunotherapeutics (1 paper)
Partner nations: France United States Canada

In The Last Decade

Agnès Hoffenbach

18 papers receiving 510 citations

Peers

Countries citing papers authored by Agnès Hoffenbach

Since Specialization

Citations

This map shows the geographic impact of Agnès Hoffenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Hoffenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Hoffenbach more than expected).

Fields of papers citing papers by Agnès Hoffenbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnès Hoffenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Hoffenbach. The network helps show where Agnès Hoffenbach may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Agnès Hoffenbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Agnès Hoffenbach Line = papers co-authored together Agnès Hoffenbach links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of age Human Vaccines & Immunotherapeutics ·Timo Vesikari, Stéphanie Pépin, Inca Kusters, Agnès Hoffenbach, Martine Denis	2012	24
2	Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age Vaccine ·Francisco Díaz‐Mitoma, Scott A. Halperin, Bruce Tapiéro, Agnès Hoffenbach, Ma Dolores Rincón González, David Radley, Susan Bradshaw, Jason Martin, John W. Boslego, Teresa M. Hesley, Prakash Bhuyan, Jeffrey L. Silber	2010	8
3	AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice Vaccine ·Catherine Caillet, Mitsue Kikuchi, G. da S. Cruz, A. B. Reichenbach, Florence Boudet, Frederick R. Vogel, Agnès Hoffenbach, 송경준, Inca Kusters	2010	30
4	Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age Vaccine ·Scott A. Halperin, Bruce Tapiéro, Francisco Díaz‐Mitoma, Barbara Law, Agnès Hoffenbach, Ma Dolores Rincón González, David Radley, 西村憲二, Jason Martin, João Paulo Pereira de Sá Canário, John W. Boslego, Teresa M. Hesley, Prakash Bhuyan, Jeffrey L. Silber	2009	15
5	Improving seasonal and pandemic influenza vaccines Influenza and Other Respiratory Viruses ·Mélanie Saville, Grenville Marsh, Agnès Hoffenbach	2008	10
6	Safety and Immunogenicity of Two Formulations of a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzaeb Conjugate-Hepatitis B Vaccine in 15 to 18 Month-Old Children Human Vaccines ·Scott A. Halperin, Joanne M. Langley, Teresa M. Hesley, Ma Dolores Rincón González, David Radley, Bruce R. Smith, Agnès Hoffenbach, John W. Boslego, Jeffrey L. Silber	2005	11
7	Lot-to-Lot Consistency of a Combined Hexavalent Diptheria-Tentanus-Acellular-Pertussis, Hepatitis B, Inactivated Polio and Haemophilus b Conjugate Vaccine, Adminstered to Healthy Chilean Infants at 2, 4 and 6 Months of Age Human Vaccines ·Rosanna Lagos, Agnès Hoffenbach, Michel Scemama, Martin Dupuy, F. Schödel, Luc Hessel, Myron M. Levine	2005	9
8	A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety Vaccine ·E. Mallet, Bernd H. Belohradsky, Rosanna Lagos, Leif Gothefors, Alexander T. Boote, Hanifah Parapat, G Kanra, Agnès Hoffenbach, J. Langue, Fishman, Shengzhi Wei, Philippe Reinert, Carl‐Erik Flodmark, S Stojanov, Johannes G. Liese, Myron M. Levine, Alma Muñoz, F. Schödel, Luc Hessel	2003	28
9	<I>Haemophilus influenzae</I> Type b Vaccine: Reconstitution of Lyophilised PRP-T Vaccine with a Pertussis-containing Paediatric Combination Vaccine, or a Change in the Primary Series Immunisation Schedule, May Modify the Serum Anti-PRP Antibody Responses Current Medical Research and Opinion ·Emmanuel Vidor, Agnès Hoffenbach, Mark A. Fletcher	2001	21
10	Haemophilus influenzaeType b Vaccine: Reconstitution of Lyophilised PRP-T Vaccine with a Pertussis-containing Paediatric Combination Vaccine, or a Change in the Primary Series Immunisation Schedule, May Modify the Serum Anti-PRP Antibody Responses Current Medical Research and Opinion ·Emmanuel Vidor, Agnès Hoffenbach, Mark A. Fletcher	2001	26
11	Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age The Pediatric Infectious Disease Journal ·Rose‐Marie Carlsson, Bo A. Claesson, Anna Skotowska-Machaj, Cristina Oprea, Marta Granström, Christine Blondeau, Agnès Hoffenbach	1998	52
12	A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal Vaccine ·François Simondon, Marie‐Pierre Préziosi, 義博高須賀, Coumba Touré Kane, Arrahmil Hasanah, Isabelle Iteman, Gary N. Sanden, Souleymane Mboup, Agnès Hoffenbach, Kim Knudsen, Nicole Guiso, Steven G.F. Wassilak, M. Cadoz	1997	205
13	Specific detection of anti-HBc antibodies with an enzyme immunoassay using recombinant HBcAg and monoclonal antibodies Journal of Virological Methods ·Carlos G. Aguirre, N Linder, J.C.M. Li, Christian Trépo, Agnès Hoffenbach, Gérard Somme	1993	3
14	Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid Journal of Medical Virology ·Carlos G. Aguirre, G Fontán, N Linder, Anil T Deslullukh, Christian Trépo, Agnès Hoffenbach, Kamel Mabrouk, Jean‐Marc Sabatier, J. Van Rietschoten, Gérard Somme	1993	20
15	HIV-1 Env, Nef , and Gag -Specific T-Cell Immunity in Mice: Conserved Epitopes in Nef P27 and Gag P25 Proteins AIDS Research and Human Retroviruses ·Frédérique Michel, Agnès Hoffenbach, Patrick Froussard, Pierre Langlade‐Demoyen, Michel Kaczorek, Marie Paule Kiény, Fernando Plata	1992	11
16	Multiple subsets of HIV‐specific cytotoxic T lymphocytes in humans and in mice European Journal of Immunology ·Nicole Chenciner, Frédérique Michel, Gilles Dadaglio, Pierre Langlade‐Demoyen, Agnès Hoffenbach, Alena Leroux, Francisco Garcia‐Pons, G Rautmann, Bruno Guy, Jean‐Marcel Guillon, Charles Mayaud, Marc Girard, Brigitte Autran, Marie‐Paule Kieny, Fernando Plata	1989	35
17	Bacillary growth, interleukin 2 production defect, and specific antibody secretion governed by different genetical factors in mice infected subcutaneously with Mycobacterium lepraemurium Cellular Immunology ·Agnès Hoffenbach, Marie‐Anne Bach	1986	8
18	Strain variation of lymphokine production and specific antibody secretion in mice infected with Mycobacterium lepraemurium Cellular Immunology ·Agnès Hoffenbach, Philippe Lagrange, Marie‐Anne Bach	1985	15

About Agnès Hoffenbach

Agnès Hoffenbach is a scholar working on Microbiology, Epidemiology, Virology, Hepatology and Immunology, having authored 18 papers that have together received 531 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (8 papers), Bacterial Infections and Vaccines (8 papers), Pneumonia and Respiratory Infections (5 papers), Hepatitis B Virus Studies (4 papers), Respiratory viral infections research (3 papers), vaccines and immunoinformatics approaches (2 papers), HIV Research and Treatment (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Microbiology (309 citations), Epidemiology (409 citations), Virology (43 citations), Infectious Diseases (117 citations) and Health (52 citations). Agnès Hoffenbach has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Mark A. Fletcher, Gary N. Sanden, Isabelle Iteman, Emmanuel Vidor, Marie‐Pierre Préziosi, Steven G.F. Wassilak, Coumba Touré Kane, M. Cadoz, Souleymane Mboup and François Simondon. Their work appears in journals such as Vaccine, Current Medical Research and Opinion, Human Vaccines, Cellular Immunology and Human Vaccines & Immunotherapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact